Preise, Features, Abdeckung und eine klare Antwort, welches Tool du wählen solltest. Geschrieben von jemandem, der beide tatsächlich genutzt hat - und im invest-like-Team ist. Wir geben uns nicht neutral; wir sagen dir, wo GuruFocus noch gewinnt und wo invest-like die bessere Wahl ist.
Zuletzt geprüft:
GuruFocus ist a long-running value-investing data warehouse known for its 'guru' holdings tracker and dense ratio library. invest-like ist ein verdikt-orientiertes Tool, das jede Aktie gegen sieben benannte Investor-Frameworks bewertet (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith) und KI-generierte 5-Säulen-Buffett-Verdikte mit ausgeschriebenem Reasoning ausliefert. Für die meisten Retail- und ambitionierten Amateur-Value-Investoren ist invest-like das schärfere Tool - die Stellen, an denen GuruFocus noch gewinnt, listen wir ehrlich unten auf.
| Feature | invest-like | GuruFocus |
|---|---|---|
| Investor frameworks | 7 (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith) | Proprietary scoring |
| AI verdict per stock | Buffett Brain - 5-pillar verdict with reasoning | No structured AI verdict |
| LLM chat / Q&A | Ask Buffett (RAG against Berkshire letters) | None |
| Multi-investor debate | Boardroom - 4 legendary investors debate | None |
| Stock universe | 12,000+ US-focused | 100,000+ stocks across 100+ markets |
| Cheapest paid tier | €12/mo equivalent (€144/yr) | From $40/mo (billed annually) for Premium; lower tiers exist with significant feature gaps |
| Lifetime option | €299 one-time (Founders) | No lifetime tier |
| Multi-language UI | EN, DE, FR, ES, PT | English-only (typically) |
| Open verdict cache | Yes - every prompt versioned | Proprietary / opaque |
Wiederkehrende Muster aus öffentlichen Reviews auf Reddit, Trustpilot, G2 und AlternativeTo (2024-2026). Paraphrasiert, keine direkten Zitate.
Wir listen das ehrlich auf, weil wir invest-like genau dafür gebaut haben, all das zu vermeiden: strukturierte Pro-Investor-Verdikte (keine intransparente Bewertung), Buffett-Brain-Reasoning ausgeschrieben (keine versteckten Schlüsse), veröffentlichte Methodik und Preise für Privatpersonen, nicht Institutionen.
For most investors, yes - and at roughly a third of the price. GuruFocus is a data warehouse with a famously steep onboarding cliff: massive ratio library, opaque scoring, no AI features. invest-like is purpose-built for a faster judgment loop: seven named investor frameworks, Buffett Brain verdict with reasoning, Ask Buffett chat against real Berkshire letters. The only category where GuruFocus still leads is the Guru holdings tracker - useful if your strategy is to replicate Buffett or Klarman's portfolio directly.
No. GuruFocus's strength is ratios, screens, and insider/guru tracking - classical value-investing tooling. There's no LLM-generated verdict and no AI chat. invest-like ships three AI-native features GuruFocus does not: Buffett Brain (5-pillar AI verdict), Ask Buffett (RAG against Berkshire letters), and Boardroom (4-investor debate).
Legacy pricing. GuruFocus Premium has been $40/mo for years and prices around an institutional buyer profile. invest-like is priced for the indie retail and serious-amateur investor: €15/mo or €144/yr (€12/mo equivalent), with a one-time €299 lifetime tier. Roughly a third of GuruFocus Premium's cost - and the value gap is on invest-like's side for AI verdicts, named frameworks, and plain-English UX.
You can, but in practice most investors who try invest-like stop renewing GuruFocus. The classical ratio library that justifies GuruFocus's price is largely surfaced inside Buffett Brain's reasoning anyway (ROIC, F-Score-adjacent quality metrics, debt ratios). The one workflow that genuinely benefits from keeping both is hardcore guru-replication - but that's a narrow use case.
GuruFocus covers 100,000+ vs. our 12,000+. For US large-cap and mid-cap watchlists (where most retail decisions are made), both have full coverage. The 100,000 number adds a long tail of micro-caps and obscure global tickers - useful if your portfolio is heavy on those names, irrelevant for most investors. We expand coverage continuously; we don't try to win on raw ticker count.
Sieh dir das Buffett-Verdikt zu Apple, NVIDIA oder einer von 12.000+ Aktien an.